Bilde av Flaten, Gøril Eide
Foto: Stina Guldbrandsen
Bilde av Flaten, Gøril Eide
Institutt for farmasi goril.flaten@uit.no +4777646169 Tromsø FARM F3.105

Gøril Eide Flaten


Professor i forskningsgruppen for Drug Transport and Delivery

Vitenskapelige arbeidsområder


  • Philip Ben Rainsford, Birta R. Sarre, Margherita Falavigna, Bjørn Olav Brandsdal, Gøril Eide Flaten, Martin Jakubec m.fl.:
    WIND-PVPA: Water/Ion NMR Detected PVPA to assess lipid barrier integrity in vitro through quantification of passive water- and ion transport
    Biochimica et Biophysica Acta - Biomembranes 2022 ARKIV / DOI
  • Zahari Vinarov, Bertil Abrahamsson, Per Artursson, Hannah Batchelor, Philippe Berben, Andreas Bernkop-Schnürch m.fl.:
    Current challenges and future perspectives in oral absorption research: An opinion of the UNGAP network
    Advanced Drug Delivery Reviews 2021 ARKIV / DOI
  • Gøril Eide Flaten, Zeljka Vanic, Natasa Skalko-Basnet :
    The Role of In Vitro Skin Models in Optimization of Dermal Drug Delivery
    CRC Press 2021
  • Marek Soltys, David Zuza, Tereza Boleslavska, Sarah Machac Akhlasova, Martin Balouch, Pavel Kovacik m.fl.:
    Drug loading to mesoporous silica carriers by solvent evaporation: A comparative study of amorphization capacity and release kinetics
    International Journal of Pharmaceutics 2021 ARKIV / DOI
  • May Wenche Jøraholmen, Selenia Ternullo, Ann Mari Holsæter, Gøril Eide Flaten, Natasa Skalko-Basnet :
    Advanced Drug Delivery Systems for Biologics
    John Wiley & Sons 2021
  • Margherita Falavigna, Sunniva Brurok Myklebost, Mette Klitgaard, Gøril Eide Flaten :
    Simultaneous assessment of in vitro lipolysis and permeation in the mucus-PVPA model to predict oral absorption of a poorly water soluble drug in SNEDDSs
    International Journal of Pharmaceutics 2021 ARKIV / DOI
  • Margherita Falavigna, Martina Pattacini, Richard Wibel, Fabio Sonvico, Natasa Skalko-Basnet, Gøril Eide Flaten :
    The Vaginal-PVPA: A Vaginal Mucosa-Mimicking In Vitro Permeation Tool for Evaluation of Mucoadhesive Formulations
    Pharmaceutics 2020 ARKIV / DOI
  • Margherita Falavigna, Mette Klitgaard, Ragna Berthelsen, Anette Mullertz, Gøril Eide Flaten :
    Predicting oral absorption of fenofibrate in lipid-based drug delivery systems by combining in vitro lipolysis with the mucus-PVPA permeability model
    Journal of Pharmaceutical Sciences 2020 ARKIV / DOI
  • Margherita Falavigna, Paul C. Stein, Gøril Eide Flaten, Massimiliano Pio Di Cagno :
    Impact of mucin on drug diffusion: Development of a straightforward in vitro method for the determination of drug diffusivity in the presence of mucin
    Pharmaceutics 2020 ARKIV / DOI
  • Margherita Falavigna, Mette Klitgaard, Erik Steene, Gøril Eide Flaten :
    Mimicking regional and fasted/fed state conditions in the intestine with the mucus-PVPA in vitro model: The impact of pH and simulated intestinal fluids on drug permeability
    European Journal of Pharmaceutical Sciences 2019 ARKIV / DOI
  • Margherita Falavigna, Mette Klitgaard, Christina Brase, Selenia Ternullo, Natasa Skalko-Basnet, Gøril Eide Flaten :
    Mucus-PVPA (mucus Phospholipid Vesicle-based Permeation Assay): An artificial permeability tool for drug screening and formulation development
    International Journal of Pharmaceutics 2018 ARKIV / DOI
  • Selenia Ternullo, Purusotam Basnet, Ann Mari Holsæter, Gøril Eide Flaten, Louis de Weerd, Natasa Skalko-Basnet :
    Deformable liposomes for skin therapy with human epidermal growth factor: The effect of liposomal surface charge
    European Journal of Pharmaceutical Sciences 2018 ARKIV / DOI
  • Philippe Berben, Annette Bauer-Brandl, Martin Brandl, Bernard Faller, Gøril Eide Flaten, Ann-Cathrine Jacobsen m.fl.:
    Drug permeability profiling using cell-free permeation tools: Overview and applications
    European Journal of Pharmaceutical Sciences 2018 ARKIV / DOI
  • Toril Andersen, Ekaterina Mishchenko, Gøril Eide Flaten, Johanna U Ericson Sollid, Sofia Mattsson, Ingunn Tho m.fl.:
    Chitosan-based nanomedicine to fight genital Candida infections: Chitosomes
    Marine Drugs 2017 FULLTEKST / ARKIV / DOI
  • Selenia Ternullo, Louis de Weerd, Ann Mari Holsæter, Gøril Eide Flaten, Natasa Skalko-Basnet :
    Going skin deep: a direct comparison of penetration potential of lipid-based nanovesicles on the isolated perfused human skin flap model
    European journal of pharmaceutics and biopharmaceutics 2017 ARKIV / DOI
  • Jaya Kumari, Gøril Eide Flaten, Natasa Skalko-Basnet, Helge Tveiten :
    Molecular transfer to Atlantic salmon ovulated eggs using liposomes
    Aquaculture 2017 ARKIV / DOI
  • Selenia Ternullo, Louis de Weerd, Gøril Eide Flaten, Ann Mari Holsæter, Natasa Skalko-Basnet :
    The isolated perfused human skin flap model: A missing link in skin penetration studies?
    European Journal of Pharmaceutical Sciences 2017 ARKIV / DOI
  • Malin Iden, Gøril Eide Flaten :
    Sjekk datoen
    13. april 2022 DATA / FULLTEKST
  • Gøril Eide Flaten, Andreas Velle :
    Morgenklubben med Loven og Co om holbarhet på solkrem
    28. april 2022
  • Jan Fredrik Frantzen, Natasa Skalko-Basnet, Gøril Eide Flaten :
    Kvinnelig rekrutteringssuksess med egen professor-filosofi
    08. mars 2022
  • Lisa Myrseth Hemmingsen, Gøril Eide Flaten, Morten B. Strøm, Natasa Skalko-Basnet :
    Membrane-active antimicrobials – in synergy with nature – the role of chitosan
    2022
  • Danielsen Veronica, Gøril Eide Flaten :
    Hvorfor havner de største nøttene øverst?
    Nyskjerrigper 2021
  • Gøril Eide Flaten :
    The importance of mucus as an absorption barrier and the use of the Mucus-PVPA
    2021
  • Gøril Eide Flaten :
    Liposomes
    2021
  • Audun Hetland, Gøril Eide Flaten, Per M Aslaksen, Joar Vittersø :
    Hjernen gjennom livet. Digitalt tilbakeblikk
    22. september 2021
  • Gøril Eide Flaten :
    NRKs pitchkonkurranse: Svaret i tarmen
    11. november 2021
  • Margherita Falavigna, Sunniva Brurok, Mette Klitgaard, Gøril Eide Flaten :
    Simultaneous in vitro lipolysis-permeation model predicts in vivo drug absorption from lipid-based formulations
    2021
  • Margherita Falavigna, Sunniva Brurok, Mette Klitgaard, Gøril Eide Flaten :
    Simultaneous in vitro lipolysis-permeation model predicts in vivo drug absorption from lipid-based formulations
    2021
  • Hans Petter Treider, Gøril Eide Flaten :
    Virker solkremen fra ifjor
    12. juni 2020
  • Gøril Eide Flaten :
    Mimicking regional and fasted/fed state conditions in the intestine with the mucus-PVPA in vitro model: The impact of food, pH and intestinal fluids on drug permeability
    2020
  • Audun Hetland, Gøril Eide Flaten, Joar Vittersø, Per M Aslaksen :
    Hjernen
    2020
  • Audun Hetland, Joar Vittersø, Per M Aslaksen, Gøril Eide Flaten :
    Hjernen gjennom livet
    2020
  • Margherita Falavigna, Mette Klitgaard, Ragna Berthelsen, Anette Mullertz, Gøril Eide Flaten :
    New combined in vitro lipolysis-permeation model predicts the in vivo absorption of fenofibrate from SNEDDS formulations
    2020
  • Margherita Falavigna, Mette Klitgaard, Ragna Berthelsen, Anette Mullertz, Gøril Eide Flaten :
    New combined in vitro lipolysis-permeation model predicts the in vivo absorption of fenofibrate from SNEDDS formulations
    2020
  • Gøril Eide Flaten :
    Lipid based nanocarriers in drug delivery
    2019
  • Margherita Falavigna, Mette Klitgaard, Erik Steene, Gøril Eide Flaten :
    Simulating the intestinal environment with the mucus-PVPA in vitro model: the impact of pH and simulated intestinal fluids on drug permeability.
    2019
  • Margherita Falavigna, Mette Klitgaard, Natasa Skalko-Basnet, Gøril Eide Flaten :
    Mucus-PVPA: an in vitro permeability screening tool for the investigation of intestinal drug absorption
    2019
  • Margherita Falavigna, Mette Klitgaard, Erik Steene, Gøril Eide Flaten :
    Simulating the intestinal environment with the mucus-PVPA in vitro model: the impact of pH and simulated intestinal fluids on drug permeability
    2019
  • Margherita Falavigna, Christina Brase, Mette Klitgaard, Natasa Skalko-Basnet, Gøril Eide Flaten :
    Mucus-PVPA : a permeability-screening tool for drug discovery and formulation development in mucosal tissues
    2018
  • Margherita Falavigna, Mette Klitgaard, Christina Brase, Selenia Ternullo, Natasa Skalko-Basnet, Gøril Eide Flaten :
    The mucus-PVPA (phospholipid vesicle-based permeation assay) as a permeability-screening tool to elucidate essential drug properties in drug discovery and formulation development in mucosal tissues
    2018
  • Gøril Eide Flaten :
    Hvordan velge de beste kandidatene for fremtidens legemidler?
    05. april 2018
  • Gøril Eide Flaten, Marit Anne Hauan, Geir Hevnskjel Ringvold :
    Observatoriet
    01. juni 2018
  • Gøril Eide Flaten, Elisabeth Øvreberg :
    42 millioner kroner for utvikling av persontilpasset medisin
    31. januar 2018
  • Gøril Eide Flaten, Marit Anne Hauan, Geir Hevnskjel Ringvold :
    Jubileumspodcast
    05. april 2018
  • Anette Holte Hansen, Gøril Eide Flaten :
    Så lenge holder solkremen din
    27. juli 2017
  • Selenia Ternullo, Louis de Weerd, Ann Mari Holsæter, Gøril Eide Flaten, Natasa Skalko-Basnet :
    A Nano-Approach to Improve Local Skin Therapy: Isolated Perfused Human Skin Flap as a Tool in Optimization
    2017
  • Margherita Falavigna, Christina Brase, Mette Klitgaard, Natasa Skalko-Basnet, Gøril Eide Flaten :
    How is mucus influencing drug permeability in the PVPA?
    2017
  • Gøril Eide Flaten :
    Drug permeability across biological barriers estimated by the PVPA
    2017
  • Gøril Eide Flaten :
    PVPA in drug screening and formulation development
    2017
  • Elisabeth Øvreberg, Gøril Eide Flaten, Natasa Skalko-Basnet :
    Er kvinnesykdommer mindre viktige?
    08. mars 2016

  • De 50 siste resultatene fra Cristin vises på siden. Se alle arbeider i Cristin her →


    Forskningsinteresser

    Sjekk ut mitt engelske personkort for mer informasjon og videopresentasjon av forskningen vår.

     

     

    Undervisning

    Underviser i følgende emner:

    FAR-1101 Farmasi grunnemne
     
    FAR-1401 Fysikalsk farmasi (emneleder)

    FAR-2401 Basal legemiddelproduksjon

    FAR-2402 Legemiddelformulering og biofarmasi

    FAR-3401 Avansert legemiddelteknologi og biofarmasi

    FAR-3043 Masteremne i nanoteknologi
     
    FAR-8043 PhD-emne i nanomedisin


    Medlem i forskningsgruppe